ERS International Congress, Paris 2018

Browse by day:
Saturday, 15.09.2018
Sunday, 16.09.2018
Monday, 17.09.2018
Tuesday, 18.09.2018
Wednesday, 19.09.2018

 

View the presentations you missed during Congress!

More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available. 

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.


What is new in idiopathic interstitial pneumonias?

Poster Discussion
Chairs: M. Kreuter (Heidelberg, Germany), A. Tzouvelekis (Athens, Greece)
Late Breaking Abstract - Phase 1, first-in-human study of OATD-01, a dual chitinase inhibitor for the treatment of respiratory diseases
J. Lipner (Warsaw, Poland), M. Lissy (Neu-Ulm, Germany), B. Dymek (Warsaw, Poland), K. Dzwonek (Warsaw, Poland), P. Dobrzanski (Warsaw, Poland), M. Kania (Warsaw, Poland), A. Golebiowski (Warsaw, Poland), S. Pikul (Warsaw, Poland)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Usefulness of surgical lung biopsies after cryobiopsies when pathological results are unspecific or show a pattern suggestive of a nonspecific interstitial pneumonia
B. Bondue (Belgium), T. Pieters (Brussels, Belgium), A. Froidure (Brussels, Belgium), V. Heinen (Liège, Belgium), P. Alexander (Ronse, Belgium), D. Hoton (Liège, Belgium), F. Dome (Liège, Belgium), M. Remmelink (Brussels, Belgium), D. Leduc (Brussels, Belgium)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Long-term nintedanib treatment in idiopathic pulmonary fibrosis (IPF): final data from INPULSIS-ON
B. Crestani (Paris, France), M. Quaresma (Ingelheim am Rhein, Germany), M. Kaye (Minneapolis, Minnesota, United States of America), T. Ogura (Yokohama, Kanagawa, Japan), W. Stansen (Ingelheim am Rhein, Germany), S. Stowasser (Ingelheim am Rhein, Germany), M. Kreuter (Heidelberg, Germany)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Proof of concept of a non-invasive screening tool to detect idiopathic pulmonary fibrosis (IPF) in an early stage
J. De Backer (Antwerp, Belgium), C. Van Holsbeke (Antwerp, Belgium), W. Vos (Antwerp, Belgium), D. Belmans (Antwerp, Belgium), G. Leemans (Antwerp, Belgium), W. De Backer (Antwerp, Belgium)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Feasibility of a homemonitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis
C. Moor (Rotterdam, Netherlands), M. Wapenaar (Rotterdam, Netherlands), J. Miedema (Rotterdam, Netherlands), J. Geelhoed (Rotterdam, Netherlands), P. Chandoesing (Rotterdam, Netherlands), M. Wijsenbeek (Rotterdam, Netherlands)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
The correlation between pathological findings of transbronchial lung cryobiopsy and high resolution CT morphology for diffuse parenchymal lung disease patients
N. Aiko (Kanagawa, Japan), T. Niwa (Kanagawa, Japan), T. Katano (Kanagawa, Japan), G. Matama (Kanagawa, Japan), K. Isomoto (Kanagawa, Japan), R. Ohtoshi (Kanagawa, Japan), E. Tabata (Kanagawa, Japan), R. Shintani (Kanagawa, Japan), S. Sadoyama (Kanagawa, Japan), H. Yamakawa (Kanagawa, Japan), S. Ikeda (Kanagawa, Japan), H. Nakagawa (Kanagawa, Japan), T. Oda (Kanagawa, Japan), R. Okuda (Kanagawa, Japan), A. Sekine (Kanagawa, Japan), H. Kitamura (Kanagawa, Japan), T. Baba (Kanagawa, Japan), S. Komatsu (Kanagawa, Japan), E. Hagiwara (Kanagawa, Japan), T. Ogura (Kanagawa, Japan)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Dehydroepiandrosterone sulfate plasma levels correlate with lung function, muscle mass and physical performance in fibrotic interstitial lung disease
S. Guler (Vancouver, Canada), S. Hur (Vancouver, Canada), S. Lear (Burnaby, Canada), P. Camp (Vancouver, Canada), P. Wilcox (Vancouver, Canada), J. Leung (Vancouver, Canada), C. Ryerson (Vancouver, Canada)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Diagnostic value of BAL lymphocytosis in patients with suspected IPF and indeterminate HRCT pattern
V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), M. Ntasiou (Athens, Greece), A. Kefalaki (Athens, Greece), A. Tsonou (Athens, Greece), D. Bouros (Athens, Greece)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Cognitive impairment and depression in patients with Idiopathic Pulmonary Fibrosis
R. Elhefny (Cairo, Egypt), A. Elessawy (Cairo, Egypt), H. Shaheen (Fayoum, Egypt), A. Mohamed (Fayoum, Egypt)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Fatigue in IPF measured by the Fatigue Assessment Scale during antifibrotic treatment
E. Bendstrup (Aarhus, Denmark), V. Skivild (Aarhus, Denmark), R. Larsen (Aarhus, Denmark), A. Aalestrup (Aarhus, Denmark), I. Terp (Aarhus, Denmark), K. Nordvig (Aarhus, Denmark), T. Prior (Aarhus, Denmark), J. Møller (Aarhus, Denmark)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia
O. Nishiyama (Osakasayama, Japan), R. Yamazaki (Osakasayama, Japan), S. Saeki (Osakasayama, Japan), H. Sano (Osakasayama, Japan), T. Iwanaga (Osakasayama, Japan), Y. Higashimoto (Osakasayama, Japan), H. Kume (Osakasayama, Japan), Y. Tohda (Osakasayama, Japan)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Effect of pamrevlumab on the UCSD-SOBQ (University of California San Diego–Shortness of Breath Questionnaire) in patients with Idiopathic Pulmonary Fibrosis (IPF)
E. Gorina (San Francisco, United States of America), T. Sekayan (San Francisco, United States of America), J. Swigris (Denver, United States of America), P. Lacamera (Boston, United States of America), R. Perez (Louisville, United States of America), M. Hamblin (Kansas City, United States of America), J. Deandrade (Birmingham, United States of America), J. Fitzgerald (Dallas, United States of America), P. Bercz (Pensacola, United States of America), M. Zhong (San Francisco, United States of America), E. Kouchakji (San Francisco, United States of America), P. Yu (San Francisco, United States of America), T. Neff (San Francisco, United States of America)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis
S. Aldhaheri (Kingston, Canada), O. Moran-Mendoza (Kingston, Canada), L. Mccarthy (Kingston, Canada)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Safety in treating dyspnea with morphine in ILD patients
S. Kronborg-White (Aarhus, Denmark), C. Uggerhøj Andersen (Aalborg, Denmark), O. Hilberg (Vejle, Denmark), E. Bendstrup (Aarhus, Denmark)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Visual and fully-automated CT analysis in acute exacerbations of idiopathic pulmonary fibrosis (IPF)
L. Kehler (Heidelberg, Germany), T. Norajitra (Heidelberg, Germany), J. Ley-Zaporozhan (Munich, Germany), A. Giannakis (Heidelberg, Germany), R. Rubtsov (Heidelberg, Germany), C. Bauer-Kemeny (Heidelberg, Germany), K. Maier-Hein (Heidelberg, Germany), C. Heussel (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Assessment of survival in patients with idiopathic pulmonary fibrosis (IPF) using quantitative HRCT indexes
S. Torrisi (Catania, Italy), S. Palmucci (Catania, Italy), R. Rosso (Catania, Italy), M. Schisano (Catania, Italy), M. Pavone (Catania, Italy), A. Vancheri (Catania, Italy), G. Sambataro (Catania, Italy), C. Crimi (Catania, Italy), A. Stefano (PalermoPaPCatania, Italy), G. Russo (Palermoatania, Italy), C. Vancheri (Catania, Italy)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Frailty is an independent predictor of number and length of hospitalizationsin patients with fibrotic ILD
S. Guler (Vancouver, Canada), J. Kwan (Vancouver, Canada), P. Wilcox (Vancouver, Canada), C. Ryerson (Vancouver, Canada)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Risk Factors for Mortality in Patients with Idiopathic Pulmonary Fibrosis Followed at Intensive Care Unit due to Acute Respiratory Failure
B. Uysaler (Izmir, Turkey), P. Ekren (Izmir, Turkey), F. Bacakoglu (Izmir, Turkey), N. Mogulkoc Bishop (Izmir, Turkey)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation